Chemistry: molecular biology and microbiology – Plant cell or cell line – per se ; composition thereof;... – Plant cell or cell line – per se – contains exogenous or...
Reexamination Certificate
2011-06-21
2011-06-21
Worley, Cathy Kingdon (Department: 1638)
Chemistry: molecular biology and microbiology
Plant cell or cell line, per se ; composition thereof;...
Plant cell or cell line, per se, contains exogenous or...
C800S298000, C800S295000, C800S288000, C435S468000
Reexamination Certificate
active
07964403
ABSTRACT:
The subject invention provides a plant cell culture for producing proteinaceous agents comprising a plant cell line stably transformed to express a transgene encoding a proteinaceous agent and a growth medium which supports the growth of said plant cell culture but which does not support the growth of Mycoplasmataceae and contains no materials of animal origin. The plant cell line is capable of being continuously passaged such that consistent transgene expression is maintained during passaging. The plant cell line is also capable of being cryopreserved such that consistent transgene expression is recovered upon recovery from cryopreservation.
REFERENCES:
patent: 5001060 (1991-03-01), Peacock et al.
patent: 5270200 (1993-12-01), Sun et al.
patent: 5273894 (1993-12-01), Strauch et al.
patent: 5276268 (1994-01-01), Strauch et al.
patent: 5290924 (1994-03-01), Last et al.
patent: 5310678 (1994-05-01), Bingham et al.
patent: 5384253 (1995-01-01), Krzyzek et al.
patent: 5484717 (1996-01-01), Zaccardi
patent: 5573932 (1996-11-01), Ellis et al.
patent: 5637489 (1997-06-01), Strauch et al.
patent: 5654184 (1997-08-01), Curtiss, III et al.
patent: 5679880 (1997-10-01), Curtiss, III et al.
patent: 5686079 (1997-11-01), Curtiss, III et al.
patent: 5773689 (1998-06-01), Thompson et al.
patent: 5773695 (1998-06-01), Thompson et al.
patent: 5824798 (1998-10-01), Tallberg et al.
patent: 5879903 (1999-03-01), Strauch et al.
patent: 5891665 (1999-04-01), Wilson
patent: 5914123 (1999-06-01), Arntzen et al.
patent: 6034298 (2000-03-01), Lam et al.
patent: 6136320 (2000-10-01), Arntzen et al.
patent: 6140075 (2000-10-01), Russell et al.
patent: 6184437 (2001-02-01), Sun et al.
patent: 6194560 (2001-02-01), Arntzen et al.
patent: 6239328 (2001-05-01), Thompson
patent: 6320101 (2001-11-01), Kaplan et al.
patent: 6395964 (2002-05-01), Arntzen et al.
patent: 7132291 (2006-11-01), Cardineau et al.
patent: 2004/0166121 (2004-08-01), Arntzen et al.
patent: 2004/0268442 (2004-12-01), Miller et al.
patent: 2005/0048074 (2005-03-01), Cardineau et al.
patent: 2006/0222664 (2006-10-01), Miller et al.
patent: 0348947 (1990-01-01), None
patent: WO 91/09957 (1991-07-01), None
patent: WO 97/27207 (1997-07-01), None
patent: WO 97/48819 (1997-12-01), None
patent: WO 00/37609 (2000-06-01), None
patent: WO 2004/098530 (2004-11-01), None
patent: WO 2004/098533 (2004-11-01), None
Etienne et al. Biotechnological applications for the improvement of coffee (Coffea Arabica L.). (2002) In Vitro Cell. Dev. Biol.-Plant; vol. 38, pp. 129-138.
Huang et al. Expression of recombinant influenze virus antigens in transgenic plants as an oral vaccine for poultry. (1999) FASEB Journal; vol. 13; abstract # 245.19.
Garcia, M. Hemagglutinin (influenza A virus). (1998) GenBank Accession AAC58998.1; p. 1 of 1.
Russell et al. Physical trauma and tungsten toxicity reduce the efficiency of biolistic transformation. (1992) Plant Phys.; vol. 98, pp. 1050-1056.
Gabridge, M. G. et al. “Culivation of Mycoplasmas in a Modified Tissue Culture Medium”Applied and Environmental Microbiology, Jun. 1976, pp. 986-989, vol. 31, No. 6.
Munoz, G. et al. “Conditions for GrowingMycoplasma canadense and Mycoplasma verecundumin a Serum-Free Medium”Applied and Environmental Microbiology, Jul. 1990, pp. 2259-2261, vol. 56, No. 7.
Taylor-Robinson, D. et al. “The prolonged persistence of mycoplasmas in culture”J. Med. Microbiol., 1987, pp. 89-92, vol. 23.
GenBank Accession No. AF077761, Mar. 23, 1999, pp. 1-8.
GenBank Accession No. X00493, Apr. 18, 2005, pp. 1-16.
Etienne, H. et al., “Biotechnological Applications for the Improvement of Coffee (Coffea arabica L.)”, In VitroCell. Dev. Biol.—Plant, Mar.-Apr. 2002, pp. 129-138, vol. 38.
Russell, J.A. et al., “Physical Trauma and Tungsten Toxicity Reduce the Efficiency of Biolistic Transformation”,Plant Physiol., 1992, pp. 1050-1056, vol. 98.
Liao, C. H. et al. “Presence of spiroplasma-inhibitory substances in plant tissue extracts”Canadian Journal of Microbiology, 1980, pp. 807-811, vol. 26, No. 7, XP-009114017.
Ogata, M. et al. “Investigation on Growth Media for Mycoplasma: Evaluation of Infusions, Peptones, Sera, Yeast Extracts and Other Supplements”Japanese Journal of Veterinary Science, 1967, pp. 259-271, vol. 29, No. 5, XP-009114016.
Fanton Matthew J.
McMillen Janis K.
Mihaliak Charles A.
Dow AgroSciences LLC
Kingdon Worley Cathy
Maciak Ronald S.
Saliwanchik Lloyd & Eisenschenk
LandOfFree
Preparation of vaccine master cell lines using recombinant... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Preparation of vaccine master cell lines using recombinant..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Preparation of vaccine master cell lines using recombinant... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2631269